IL6 and cystic fibrosis: Most importantly, stimulation with the SARS-CoV-2 S protein led to a remarkable induction of IL-6 release (14-fold increase) in primary hBEC grown at the air-liquid interface derived from healthy donors while induced a very weak response in CF primary cells (Fig. 7d).